A detailed history of Kula Investments, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 23,023 shares of RNA stock, worth $728,447. This represents 0.09% of its overall portfolio holdings.

Number of Shares
23,023
Previous 17,958 28.2%
Holding current value
$728,447
Previous $398 Million 11.31%
% of portfolio
0.09%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$15.35 - $25.65 $77,747 - $129,917
5,065 Added 28.2%
23,023 $353 Million
Q4 2022

Feb 14, 2023

BUY
$10.06 - $22.66 $180,657 - $406,928
17,958 New
17,958 $398 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.65B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.